EUFEMED – Joint Conference of European Human Pharmacological Societies 2015

Posted On 2-Feb-2015 by Sam Welgemoed

Hosted by the Belgian Association of Phase I Units (BAPU) and organised in collaboration with the European early clinical drug development associations from France (Club Phase 1), Germany (AGAH) and the United Kingdom (AHPPI), EUFEMED welcomes you to attend the 3rd Joint Conference of European Human Pharmacological Societies, taking place 21-22 May 2015 in Brussels, in celebration of its foundation.

The meeting will assess the competitiveness of Europe in early clinical drug development, the impact of the new European regulation as well as the challenges encountered in conducting exploratory clinical studies in a continuously changing environment.

For further information and to regsiter vist the EUFEMED website: www.eufemed.eu

Comments Off on EUFEMED – Joint Conference of European Human Pharmacological Societies 2015

Drug Discovery of the Year 2015 nominations

Posted On 1-Sep-2014 by Steffan Stringer

The British Pharmacological Society is accepting nominations for its third Drug Discovery of the Year award. The award was established by the Society in 2012 to demonstrate the importance of pharmacology in the development of new medicines, and to reward the achievements of the teams of scientists who discover and develop these drugs.

Previous winners

Drug Discovery of the Year 2013: the Genentech team who developed vismodegib

Drug Discovery of the Year 2014: the GlaxoSmithKline team responsible for trametinib

Professor Humphrey Rang, BPS President, comments:

“The British Pharmacological Society was encouraged by the exceptional quality of the nominations received last year. I am delighted to announce the call for submissions to our third Drug Discovery of the Year award and to welcome nominations from across all disease areas that demonstrate the importance of both pre-clinical and clinical pharmacology in translating early discoveries into medicines that benefit patients.”

The Society’s Industry Committee will consider nominations for the discovery team behind a drug – whether a large or a small molecule – that best fulfils the following criteria:

  • preclinical to clinical translation shows the importance of both preclinical and clinical pharmacology in the drug discovery/development process
  • gained regulatory approval within the last three years in the EU and/or US
  • has a significant impact on an unmet medical need
  • first-in-class, or is a significant improvement over other drugs in the class
  • mechanism of action known

Nominations must be received by 1 October 2014. The winning team will be publicly announced during the Society’s flagship meeting Pharmacology 2014, held in London on 16-18 December 2014, and attended by an anticipated 1,000 pharmacologists.

The award does not promote the administration, consumption, prescription, purchase, recommendation, sale, supply or use of the winning medicine; nor does it pre-empt any regulatory decisions. Further information is available from www.bps.ac.uk.

Comments Off on Drug Discovery of the Year 2015 nominations

REFORMATTED 2014 AHPPI ANNUAL MEETING!

Posted On 3-Jul-2014 by Kristy

COMPLETELY NEW FORMAT FOR 2014 AHPPI ANNUAL MEETING!

Academy of Medical Sciences, London,

Thursday 30th October 2014.

We are pleased to announce that AHPPI members are invited to speak at this year’s conference. In contrast to previous years, the meeting will be divided into two parts; the first part being a selection of ten-minute presentations by our members and the latter part a dynamic discussion to guide the future of the AHPPI.

Further information can be found here.

Comments Off on REFORMATTED 2014 AHPPI ANNUAL MEETING!

2014 AHPPI CONFERENCE ANNOUNCEMENT

Posted On 24-Jan-2014 by Kristy

Thursday October 30th

13.30 – 17.30

Academy of Medical Sciences, London.

Further details to follow soon.

Comments Off on 2014 AHPPI CONFERENCE ANNOUNCEMENT

Introductory Course on Human Pharmacology / Translational Medicine – Part II, Heidelberg (Germany), 13th – 15th February 2014

Posted On 24-Jan-2014 by Kristy

The AGAH board invite new and existing participants to the continuation of the November 2013 workshop.  This course provides a basic training in Human Pharmacology and is addressed to postgraduates in life sciences interested in early clinical development of medicinal products.  The program, further details and the online form can be found here,

0 Comments

Club Phase 1 invite AHPPI members to 4th February meeting

Posted On 24-Jan-2014 by Kristy

Predictive Toxicology and Clinical Pharmacology, Paris (France), 4th February 2014

Our colleagues at Club Phase 1 invite AHPPI members to their upcoming annual meeting.  Interested parties should register no later than 25th January 2014. Further details can be found here.

 

Comments Off on Club Phase 1 invite AHPPI members to 4th February meeting

AVAILABLE NOW: 2013 AHPPI Conference Presentations

Posted On 1-Nov-2013 by Kristy

Translational PD Studies in Early Stage CNS Drug Development

24th October 2013 at Academy of Medical Sciences

This year’s AHPPI event was highly successful and well attended. It has been praised by delegates for the high quality of information and informative presentations.  We’d like to thank our highly acclaimed speakers, our sponsors and of course the delegates for their part in making the afternoon so enjoyable. Click here to view the presentations.

Comments Off on AVAILABLE NOW: 2013 AHPPI Conference Presentations

BPS invite AHPPI members to Pharmacology 2013

Posted On 9-Jul-2013 by Kristy

BPSimage001

On behalf of the British Pharmacological Society, we are delighted to invite AHPPI members to register for Pharmacology 2013, which will be held on 17–19 December at the Queen Elizabeth II (QEII) Conference Centre, London, UK. Formerly known as the BPS Winter Meeting, Pharmacology 2013 reaffirms our commitment to ‘Today’s science, tomorrow’s medicines’ by providing the highest quality scientific content and invaluable networking opportunities for attendees from the UK and overseas.

AHPPI members can register from £125 per day or £295 for three days – simply login to the registration website. BPS members are eligible for FREE registration through the BPS members’ area and it is usually less expensive to join the Society than to pay non-member registration fees. For information on membership, please email Paul Tizard at the BPS office.

Why register for Pharmacology 2013?

  • BPS will be opening up this year’s meeting to a greater number of attendees than ever before, as we decided to move to a new, larger space within the QEII Conference Centre
  • High quality sessions and expert speakers are already confirmed in the scientific programme, with nine symposia covering the whole spectrum of pharmacology including a session devoted to the Drug Discovery of the Year
  • Poster and oral presentations are a key component of the meeting, and you are warmly invited to submit your abstract by Monday 16 September 2013
  • Networking opportunities continue to be a focus, so remember to book your place at the Welcome Reception and Annual Dinner & Prize-Giving when you register

Don’t take our word for it!

In our 2012 Meetings Survey, 92% of respondents rated the scientific content of BPS meetings as high quality and 90% agreed that they would recommend BPS meetings to their colleagues. To find out more, watch our video with highlights from last year’s meeting.

We look forward to you joining us in London and hope you will share the details of this meeting with your colleagues. If you have any queries or need further information, please contact the BPS Meetings team on meetings@bps.ac.uk or call +44 (0)20 7239 0176.

Best wishes,

Professor Phil Routledge, BPS President

&

Professor David Webb, BPS Vice President – Meetings

Comments Off on BPS invite AHPPI members to Pharmacology 2013

BPS Drug Discovery of the Year 2013 opens for nominations

Posted On 25-Jun-2013 by Kristy

Judges welcome submissions from across the spectrum of pharmacology

The British Pharmacological Society (BPS) proudly announces that it is now accepting nominations for its Drug Discovery of the Year award. The award was established by BPS to demonstrate the importance of pharmacology in the development of new medicines, and to reward the achievements of the teams of scientists who discover new drugs.

Drug Discovery of the Year was presented last year to the team who developed vismodegib for the treatment of advanced basal cell carcinoma. The announcement followed judging by the BPS Industry Committee, consisting of experts in industrial pharmacology, who reviewed nominations from across the world and a range of disease areas.

Professor Philip Routledge, BPS President, comments: “I am delighted to announce the details of Drug Discovery of the Year and to welcome submissions from across the whole spectrum of pharmacology. BPS intends to build on the number and high quality of the nominations received in 2012, all of which demonstrated the importance of pharmacology in drug discovery.”

This year, BPS Industry Committee will consider nominations for the discovery team behind a drug – whether a large or a small molecule – that best fulfils the following criteria:

  • gained regulatory approval within the last 3 years in the EU and/or US
  • preclinical to clinical translation shows the importance of pharmacology in the drug discovery/development process
  • has a significant impact on an unmet medical need
  • first-in-class, or is a significant improvement over other drugs in the class
  • mechanism of action known

Nominations must be received by 1 October 2013. The winning team will be publicly announced during the BPS flagship meeting Pharmacology 2013, held in London 17-19 December 2013 and attended by an anticipated 1,000 pharmacologists.

The award neither promotes the administration, consumption, prescription, purchase, recommendation, sale, supply or use of the winning medicine; nor does it pre-empt any regulatory decisions. Further information is available from www.bps.ac.uk

0 Comments

Speakers Confirmed for AHPPI Conference, 24th October 2013

Posted On 6-Jun-2013 by Kristy

We are pleased to confirm the following panel of speakers for this year’s conference, “Translational PD Studies in Early Stage CNS Drug Development”.  Click here for further details.

~ Prof. Steve Williams, King’s College London ~

~ Prof. Derk-Jan Dijk, University of Surrey ~

~ Prof. Praveen Anand, Imperial College London ~

~ Prof. Keith Wesnes, Bracket Global ~

~ Dr. John Connell, Icon Development Solutions ~

 

0 Comments